Big Pharma Split Corp.
PRM.TO · TSX
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | CA$13 | CA$15 | CA$18 | CA$33 |
| - Cash | CA$2 | CA$1 | CA$2 | CA$0 |
| + Debt | CA$12 | CA$12 | CA$11 | CA$10 |
| Enterprise Value | CA$23 | CA$26 | CA$27 | CA$43 |
| Revenue | -CA$1 | CA$1 | CA$1 | CA$1 |
| % Growth | -221.8% | -33.9% | 54.8% | – |
| Gross Profit | -CA$1 | CA$1 | CA$1 | CA$1 |
| % Margin | 100% | 79.1% | 85.4% | 100% |
| EBITDA | CA$0 | -CA$1 | CA$2 | -CA$0 |
| % Margin | -0% | -201.8% | 135.3% | -62.2% |
| Net Income | -CA$0 | -CA$2 | CA$1 | -CA$0 |
| % Margin | 54.4% | -241.7% | 111.3% | -10.9% |
| EPS Diluted | -0.41 | -1.54 | 0.99 | -0.066 |
| % Growth | 73.4% | -255.6% | 1,604.6% | – |
| Operating Cash Flow | CA$1 | -CA$1 | -CA$0 | -CA$1 |
| Capital Expenditures | -CA$0 | CA$0 | CA$0 | CA$0 |
| Free Cash Flow | CA$1 | -CA$1 | -CA$0 | -CA$1 |